Search results
Results from the WOW.Com Content Network
Common symptoms of viral meningitis include fever, headache, neck ... fluids and pain ... which protects against four types of meningococcal bacteria that cause meningitis. This vaccine, says ...
Saudi Arabia requires vaccination with the quadrivalent vaccine for international travellers to Mecca for Hajj. [9] [14] Meningococcal vaccines are generally safe. [9] Some people develop pain and redness at the injection site. [9] Use in pregnancy appears to be safe. [13] Severe allergic reactions occur in less than one in a million doses. [9]
Neck stiffness, Texas meningitis epidemic of 1911–12. In adults, the most common symptom of meningitis is a severe headache, occurring in almost 90% of cases of bacterial meningitis, followed by neck stiffness (the inability to flex the neck forward passively due to increased neck muscle tone and stiffness). [16]
Meningitis A, C, Y and W-135 vaccines can be used for large-scale vaccination programs when an outbreak of meningococcal disease occurs in Africa and other regions of the world. Whenever sporadic or cluster cases or outbreaks of meningococcal disease occur in the US, chemoprophylaxis is the principal means of preventing secondary cases in ...
The first, known commonly as meningitis, can cause a fever, headache and stiff neck, or progress to more severe symptoms like nausea, vomiting, light sensitivity and mental confusion.
The CDC recommends that 11- to 12-year-olds get a MenACWY vaccine, with a booster dose at 16 years old. Teens and young adults ages 16 through 23 also may get a different meningitis vaccine ...
Penbraya is a pentavalent conjugate vaccine developed by Pfizer for the prevention of invasive meningococcal disease in people 10 through 25 years of age. [4] Invasive meningococcal disease, caused by the bacterium Neisseria meningitidis, can lead to serious conditions such as meningitis (inflammation of the brain and spinal cord lining) and sepsis. [5]
NmVac4-A/C/Y/W-135 is the commercial name for a polysaccharide vaccine that protects against meningococcal meningitis caused by Neisseria meningitidis, specifically the serotypes A, C, Y, and W-135. This vaccine is part of a broader group of meningococcal vaccines.